Michael Brian Bell - 15 Mar 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Financial Officer
Signature
/s/ John Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
15 Mar 2023
Transactions value $
-$45,606
Form type
4
Filing time
16 Mar 2023, 17:30:27 UTC
Previous filing
17 Jan 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +4,931 +1.22% $0 8,982 15 Mar 2023 Direct
transaction GH COMMON STOCK Tax liability -$45,606 -1,703 -18.96% $26.78 7,279 15 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -4,931 -25% $0 14,796 15 Mar 2023 COMMON STOCK 4,931 $0 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F2 Not applicable for Restricted Stock Units.